Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Dolnik

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Nature Communications|February 24, 2022
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myelomaYuen Lam Dora Ng, Evelyn Ramberger, Stephan R Bohl, et al.
Oncotarget|December 10, 2017
<i>Protein phosphatase 4 regulatory subunit 2 (PPP4R2)</i> is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.
Oncotarget|December 10, 2017
Analysis of <i>NPM1</i> splice variants reveals differential expression patterns of prognostic value in acute myeloid leukemiaMalgorzata Zajac, Anna Dolnik, Grazyna Stasiak, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 4, 2025
Genomic evolution of high-risk soft tissue sarcomas under thermo- and chemotherapeutic selection pressureMaren Schmiester, Antonia Freytag, Bernhard Gillissen, et al.
Blood Advances|May 5, 2021
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myelomaStephan R Bohl, Laura K Schmalbrock, Imke Bauhuf, et al.
Blood Advances|December 1, 2022
Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLsElisa Donato, Nadia Correia, Carolin Andresen, et al.
Blood Advances|August 15, 2023
AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technologyMarius-Konstantin Klever, Eric Sträng, Sara Hetzel, et al.
Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Leukemia|October 3, 2018
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional careHartmut Döhner, Anna Dolnik, Lin Tang, et al.
Haematologica|October 15, 2020
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1Eugen Tausch, Philipp Beck, Richard F Schlenk, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Nature Communications|February 24, 2022
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myelomaYuen Lam Dora Ng, Evelyn Ramberger, Stephan R Bohl, et al.
Oncotarget|December 10, 2017
<i>Protein phosphatase 4 regulatory subunit 2 (PPP4R2)</i> is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repairJulia K Herzig, Lars Bullinger, Alpaslan Tasdogan, et al.
Oncotarget|December 10, 2017
Analysis of <i>NPM1</i> splice variants reveals differential expression patterns of prognostic value in acute myeloid leukemiaMalgorzata Zajac, Anna Dolnik, Grazyna Stasiak, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 4, 2025
Genomic evolution of high-risk soft tissue sarcomas under thermo- and chemotherapeutic selection pressureMaren Schmiester, Antonia Freytag, Bernhard Gillissen, et al.
Blood Advances|May 5, 2021
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myelomaStephan R Bohl, Laura K Schmalbrock, Imke Bauhuf, et al.
Blood Advances|December 1, 2022
Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLsElisa Donato, Nadia Correia, Carolin Andresen, et al.
Blood Advances|August 15, 2023
AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technologyMarius-Konstantin Klever, Eric Sträng, Sara Hetzel, et al.
Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Leukemia|October 3, 2018
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional careHartmut Döhner, Anna Dolnik, Lin Tang, et al.
Haematologica|October 15, 2020
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1Eugen Tausch, Philipp Beck, Richard F Schlenk, et al.
Pageof 5